BioSpace News Archive

Nipro Vascular Company Brings the First Dual-Modality Intravascular Imaging System and Catheter to the World’s Largest Imaging Market.

Potential New Treatment Option for a Severe and Disabling Inflammatory Hand Disease

Dr. Orfali replaced Dr. Mark Goldberg, who was acting as interim Chief Medical Officer.

Puma Biotechnology, Inc. announced that Health Canada has accepted for review the Company’s New Drug Submission (NDS) for the medicinal product NERLYNX® (neratinib) for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer following adjuvant trastuzumab-based therapy.

Purdue Pharma L.P. announced completion of a Phase 1b dose-ranging study of a novel, potential first-in-class small molecule being investigated for its utility in insomnia associated with alcohol cessation.

Platform developed to break down data barriers and simplify the access and the ability to utilize health data for professionals.

Molecular tag, test and track platform provides physical identity and traceability for Everledger digital platform with leather supply chain as first target market

Concord Medical Services Holdings Limited announced that Concord Medical signed a cooperation agreement with Peking University International Hospital.

Abzena plc has entered into a master service agreement with one of America’s leading academic medical centres, NYU Langone Health (New York, US).

NovaBay® Pharmaceuticals, Inc. announces that it will report second quarter 2018 financial results after market close on Tuesday, August 7.